-
Kristin Wipfler, PhD: Impact on Access to Methotrexate in the Post-Roe Era
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk.
-
Matthew C. Baker, MD, MS: Sarcoidosis Incidence after mTOR Inhibitor Treatment
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk.
-
Robert M. Hamilton, MD, MHSc, FRCP(C): Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block
Robert M. Hamilton, MD, MHSc, FRCP(C), will discuss the poster “Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block” in a Monday afternoon Ignite Talk.
-
Sabine Sparre Dieperink, MD: The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry
Sabine Sparre Dieperink, MD, will discuss the poster “The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Regis” in a Monday…
-
Marc Gurwith, MD, JD: A Double-Blind Ascending Dose Placebo-Controlled Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia
Marc Gurwith, MD, JD, will discuss the poster “A Double-Blind Ascending Dose Placebo-Controlled Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia” in a Sunday morning Ignite Talk.
-
Cristiana Sieiro Santos, MD: Immune Responses to mRNA Vaccines Against SARS-CoV-2 in Patients with Immune-mediated Inflammatory Rheumatic Diseases
Cristiana Sieiro Santos, MD, will discuss the poster “Immune Responses to mRNA Vaccines Against SARS-CoV-2 in Patients with Immune-mediated Inflammatory Rheumatic Diseases” in a Sunday afternoon Ignite Talk.
-
Lori Tucker, MD, FRCPC: A Cross-Sectional Description of Physical Activity (PA) in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis)
Lori Tucker, MD, FRCPC, will discuss the poster “A Cross-Sectional Description of Physical Activity (PA) in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis)” in a Sunday afternoon Ignite Talk.
-
Catherine April Bingham, MD: Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Outcome Improvement for Children with Juvenile Idiopathic Arthritis
Catherine April Bingham, MD, will discuss the poster “Radiographic Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Outcome Improvement for Children with Juvenile Idiopathic Arthritis” in a Sunday afternoon Ignite Talk.
-
Rochelle L. Castillo, MD, MS: Spatial Transcriptomics Stratifies Health and Psoriatic Disease Severity by Emergent Cellular Ecosystems
Rochelle L. Castillo, MD, MS, will discuss the poster “Spatial Transcriptomics Stratifies Health and Psoriatic Disease severity by Emergent Cellular Ecosystems” in a Saturday afternoon Ignite Talk.
-
Niti Goel, MD: Lack of Racial and Ethnic Diversity in Clinical Trials of Psoriatic Arthritis
Niti Goel, MD, will discuss the poster “Lack of Racial and Ethnic Diversity in Clinical Trials of Psoriatic Arthritis” in a Saturday afternoon Ignite Talk.